Skip to content
Skills Library
Science & research · Planning

group-sequential-methods

/group-sequential-methods

Group sequential design methods for interim analyses, alpha spending, and futility stopping. Use when designing trials with interim looks or implementing spending functions.

Licence
MIT
Last repository change
27.05.2026

Assessment and security

100/ 100Class: good
Format25 / 25
Frontmatter with name and description, valid name, description up to 1,024 characters, name matching the folder.
Discoverability25 / 25
Description explains when to use the skill, has a reasonable length and uses third person.
Content35 / 35
At least 150 words and at most 500 lines, headings, step lists, examples or code.
Hygiene15 / 15
No placeholders such as TODO, no Windows paths, with a licence.
Riskno signals detected in the scan
Files in this package
1
Scripts
0
HTML comments
0
URLs in SKILL.md
0
Deprecation

No signals detected. Repository changed on 27.05.2026, without references to retired models or APIs.

Licence

MIT, open: use and modify while retaining author attribution.

What it does and when to use it

Group sequential design methods for interim analyses, alpha spending, and futility stopping. Use when designing trials with interim looks or implementing spending functions.

Original author description

Group sequential design methods for interim analyses, alpha spending, and futility stopping. Use when designing trials with interim looks or implementing spending functions.

How it works

  1. When to Use This Skill
  2. Fundamental Concepts
  3. Alpha Spending Functions
  4. Futility Boundaries
  5. simtrial GS Implementation
  6. Different Tests Across Analyses
  7. Common GS Patterns
  8. Operating Characteristics
  9. Best Practices
  10. Regulatory Considerations
Original SKILL.md headings · 343 lines, 1,289 words
SKILL.md preview
---
name: group-sequential-methods
description: Group sequential design methods for interim analyses, alpha spending, and futility stopping. Use when designing trials with interim looks or implementing spending functions.
---

# Group Sequential Methods

## When to Use This Skill

- Designing group sequential trials with interim analyses
- Implementing alpha spending functions
- Setting futility stopping rules
- Calculating information fractions
- Using sim_gs_n() for GS simulations
- Integrating with gsDesign2 package

## Fundamental Concepts

### Group Sequential Design

A group sequential design allows for:
- **Early stopping for efficacy**: If treatment effect is larger than expected
- **Early stopping for futility**: If treatment effect is unlikely to reach significance
- **Reduced expected sample size**: When treatment effect is present

### Information Fraction

Information fraction at analysis k:
```
I_k / I_K = (events at analysis k) / (total planned events)
```

For time-to-event trials, information ≈ number of events.

### Type I Error Spending

The key constraint is that the design controls the overall Type I error at the planned alpha level. Spending functions define cumulative alpha spending over information time, and boundaries are derived using the joint distribution of sequential test statistics. They are not obtained by simply assigning independent nominal alpha levels to each look.

## Alpha Spending Functions

### O'Brien-Fleming (OBF)

**Properties:**
- Conservative at early analyses
- Nearly full alpha at final analysis
- Difficult to stop early
- Maintains nominal Type I error

**Formula:**
```
α*(t) = 2 - 2Φ(z_{α/2} / √t)
```

**When to Use:**
- Want maximum power at final analysis
- Early efficacy stopping unlikely
- Regulatory preference for conservative early bounds

### Pocock

**Properties:**
- Equal spending at each analysis
- Easier to stop early
- Inflated final alpha
- Lower power at final analysis

**Formula:**
```
α*(t) = α × log(1 + (e-1)t)
```

**When to Use:**
- Early stopping is a priority
- Treatment effect expected to be large
- Willing to sacrifice final analysis power

### Hwang-Shih-DeCani (HSD)

**Properties:**
- Flexible family indexed by γ
- γ = -4: Similar to OBF
- γ = 1: Similar to Pocock
- γ = 0: Linear (Pocock-like)

**Formula:**
```
α*(t) = α × (1 - e^{-γt}) / (1 - e^{-γ})
```

**When to Use:**
- Want flexibility between OBF and Pocock
- Customized spending pattern needed

### Spending Function Comparison

| Function | Early Spending | Final Power | Early Stopping |
|----------|---------------|-------------|----------------|
| OBF | Low | High | Difficult |
| Pocock | High | Lower | Easier |
| HSD(γ=-4) | Low | High | Difficult |
| HSD(γ=1) | High | Lower | Easier |

## Futility Boundaries

### Binding Futility

- If futility boundary crossed, trial MUST stop
- Affects Type I error calculation
- More powerful than non-binding

### Non-Binding Futility

- Crossing futility boundary is advisory
- Trial can continue at investigator discretion
- Conservative: assumes no early stopping for futility in Type I error

### Beta-Spending for Futility

Similar to alpha-spending, but for Type II error:
```
β*(t) = spending function × β
```

## simtrial GS Implementation

### create_cut() - Define Analysis Timing

```r
# Interim Analysis 1
ia1_cut <- create_cut(
  planned_calendar_time = 20,        # Minimum 20 months
  target_event_overall = 100,        # Target 100 events
  max_extension_for_target_event = 24,  # Wait up to 24 months for events
  min_n_overall = 200,               # At least 200 enrolled
  min_followup = 12                  # 12 months minimum follow-up
)

# Interim Analysis 2
ia2_cut <- create_cut(
  planned_calendar_time = 32,
  target_event_overall = 200,
  max_extension_for_target_event = 34,
  min_time_after_previous_analysis = 10  # At least 10 months after IA1
)

# Final Analysis
fa_cut <- create_cut(
  planned_calendar_time = 45,
  target_event_overall = 350
)
```

### sim_gs_n() - Run GS Simulations

```r
library(simtrial)
library(gsDesign2)

# Define enrollment
enroll_rate <- define_enroll_rate(
  duration = c(4, 12),
  rate = c(10, 30)
)

# Define failure rates
fail_rate <- define_fail_rate(
  duration = c(3, 100),
  fail_rate = log(2)/9,
  hr = c(1, 0.6),
  dropout_rate = 0.001
)

# Run simulation
results <- sim_gs_n(
  n_sim = 1000,
  sample_size = 400,
  enroll_rate = enroll_rate,
  fail_rate = fail_rate,
  test = wlr,
  cut = list(ia1 = ia1_cut, ia2 = ia2_cut, fa = fa_cut),
  weight = fh(rho = 0, gamma = 0)
)
```

### Integration with gsDesign2

```r
library(gsDesign2)

# Design with gsDesign2
design <- gs_design_ahr(
  enroll_rate = define_enroll_rate(duration = c(4, 12), rate = c(10, 30)),
  fail_rate = define_fail_rate(
    duration = c(3, 100),
    fail_rate = log(2)/9,
    hr = c(1, 0.6),
    dropout_rate = 0.001
  ),
  alpha = 0.025,
  beta = 0.1,
  analysis_time = c(24, 36, 48),
  upper = gs_spending_bound,
  upar = list(sf = gsDesign::sfLDOF, total_spend = 0.025),
  lower = gs_spending_bound,
  lpar = list(sf = gsDesign::sfHSD, param = -4, total_spend = 0.1)
) |> to_integer()

# Simulate with design object
sim_results <- sim_gs_n(
  n_sim = 1000,
  sample_size = max(design$analysis$n),
  enroll_rate = design$enroll_rate,
  fail_rate = design$fail_rate,
  test = wlr,
  cut = NULL,  # Auto-generated from design
  original_design = design,
  weight = fh(rho = 0, gamma = 0)
)
```

### Bound Updates with sim_gs_n()

When using `original_design`, sim_gs_n() can compute updated bounds:

```r
# Results include planned and updated bounds
results <- sim_gs_n(
  # ... parameters ...
  original_design = design,
  ia_alpha_spending = "min_planned_actual",  # Conservative
  fa_alpha_spending = "full_alpha"           # Spend full alpha at FA
)

# Output includes:
# - planned_upper_bound, planned_lower_bound
# - updated_upper_bound, updated_lower_bound
```

**Alpha Spending Options:**

| ia_alpha_spending | Description |
|-------------------|-------------|
| "min_planned_actual" | Conservative: min of planned and actual |
| "actual" | Spend based on actual information |

| fa_alpha_spending | Description |
|-------------------|-------------|
| "full_alpha" | Spend remaining alpha at final |
| "info_frac" | Spend based on information fraction |

## Different Tests Across Analyses

```r
# Different tests at each analysis
ia1_test <- create_test(wlr, weight = fh(rho = 0, gamma = 0))
ia2_test <- create_test(wlr, weight = fh(rho = 0, gamma = 0.5))
fa_test <- create_test(wlr, weight = mb(delay = 6, w_max = Inf))

results <- sim_gs_n(
  n_sim = 1000,
  sample_size = 400,
  enroll_rate = enroll_rate,
  fail_rate = fail_rate,
  test = list(ia1 = ia1_test, ia2 = ia2_test, fa = fa_test),
  cut = list(ia1 = ia1_cut, ia2 = ia2_cut, fa = fa_cut)
)
```

## Common GS Patterns

### Two-Look Design (1 IA + FA)

```r
# IA at 50% information, FA at 100%
ia_cut <- create_cut(target_event_overall = 150)  # 50%
fa_cut <- create_cut(target_event_overall = 300)  # 100%

sim_gs_n(
  n_sim = 1000,
  sample_size = 400,
  test = wlr,
  cut = list(ia = ia_cut, fa = fa_cut),
  weight = fh(0, 0)
)
```

### Three-Look Design (2 IA + FA)

```r
# Standard 33%, 67%, 100% information
ia1_cut <- create_cut(target_event_overall = 100)
ia2_cut <- create_cut(target_event_overall = 200)
fa_cut <- create_cut(target_event_overall = 300)
```

### Event-Driven with Calendar Constraints

```r
# Events-based but with minimum calendar time
ia_cut <- create_cut(
  target_event_overall = 150,
  planned_calendar_time = 18,  # At least 18 months
  max_extension_for_target_event = 24  # Max 24 months
)
```

## Operating Characteristics

### Key Metrics to Evaluate

1. **Power**: P(reject H0 | H1 true)
2. **Type I Error**: P(reject H0 | H0 true)
3. **Expected Sample Size**: E[N] under H0 and H1
4. **Expected Events**: E[events] at each analysis
5. **Stopping Probabilities**: P(stop at analysis k)

### Simulation Summary

```r
# Summarize simulation results
results_summary <- results |>
  group_by(analysis) |>
  summarise(
    mean_events = mean(event),
    mean_z = mean(z),
    power = mean(z < qnorm(0.025)),  # One-sided
    .groups = "drop"
  )
```

## Best Practices

1. **Information Fraction**: Target evenly spaced (e.g., 50%, 100% or 33%, 67%, 100%)
2. **Alpha Spending**: OBF is default for most regulatory submissions
3. **Futility**: Use non-binding to preserve flexibility
4. **Validation**: Compare simulated power to gsDesign analytical results
5. **Documentation**: Record all boundary calculations for regulatory submission
6. **Parallelization**: Use `plan("multisession")` for large simulations

## Regulatory Considerations

- Pre-specify number and timing of interim analyses
- Pre-specify spending function and parameters
- Document stopping rules clearly in protocol
- Consider DSMB recommendations for unblinded reviews
- Maintain blinding for operational team

Versions

The database has no other skills named group-sequential-methods.

Database snapshot: 13.11.2026 · package version 47d7ec3200f8 (SHA-256 digest of the entire package)

Downloads in the last 30 days: 0 · ranking

Report a problem with this skill: harmful content, incorrect descriptions or an author’s removal request.

Similar skills

  • 100grad-mixed-methods
    Design and conduct mixed methods research using convergent, explanatory sequential, or exploratory sequential strategies with genuine integration of qualitative and quantitative strands. Use this skill when the user needs to choose a mixed methods design, integrate qualitative…
  • 100alterlab-mixed-methods
    Mixed methods research design and integration strategies for combining qualitative and quantitative approaches. Use when planning convergent, explanatory sequential, exploratory sequential, embedded, transformative, or multiphase designs; when integrating diverse data sources…
  • 95mixed-methods
    Mixed methods research design and integration strategies for combining qualitative and quantitative approaches. Use when planning convergent, explanatory sequential, exploratory sequential, embedded, transformative, or multiphase designs; when integrating diverse data sources…
  • 95bio-clinical-biostatistics-adaptive-designs
    Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population…

Feedback and reports

Your message goes to Bartosz Sokoliński. An email address is needed only for a reply. See the privacy policy.